Head and Neck Cancer
Head and Neck Cancer
Advertisement
Jordana JampelHead and Neck Cancer | November 11, 2024
Researchers aimed to find a marker to accurately predict the prognosis of HNSCC and to find novel immune targets.
Read More
Jordana JampelHead and Neck Cancer | November 7, 2024
The combo's use for conjunctival melanoma demonstrates the combinations high efficacy in treating complex disease.
Laura LitwinHead and Neck Cancer | October 23, 2024
The single-center, prospective study evaluated patient questionnaires to assess quality of life and physical function.
Rob DillardHead and Neck Cancer | October 23, 2024
BANF1 is a prognostic biomarker that can promote tumor expression in patients with HNSCC.
Rob DillardHead and Neck Cancer | September 27, 2024
Oral bacteria are a risk factor for head and neck squamous cell cancer.
Rob DillardHead and Neck Cancer | September 20, 2024
A novel predictive digital pathology biomarker demonstrates high predictive response in HNC.
Rob DillardHead and Neck Cancer | August 21, 2024
A multi-university research collaboration spearheaded by Rice University has been award $18 million for breast, HNC research.
Rob DillardHead and Neck Cancer | August 13, 2024
Daily cannabis use over a period of years may be linked to a significantly increased risk of head and neck cancers.
Rob DillardHead and Neck Cancer | August 12, 2024
An AI-based tool demonstrated superior performance in the diagnosis of head and neck squamous cell carcinoma.
Rob DillardHead and Neck Cancer | June 18, 2024
Primary care providers are highly involved in opioid prescribing for HNC survivors.
Rob DillardASCO 2024 | June 6, 2024
Edmonton Symptom Assessment System completion rates need to be improved in patients with HNC.
Rob DillardASCO 2024 | May 30, 2024
Patients with head and neck cancer have increased rates of suicide compared with patients with other cancers.
Rob DillardHead and Neck Cancer | April 29, 2024
A gene model has the potential to serve as a prognostic indicator for patients with head and neck squamous cell carcinoma.
Rob DillardHead and Neck Cancer | April 12, 2024
The use of a 3D variable flip angle mapping technique is effective in patients with head and neck cancer undergoing CRT.
Patrick DalyHead and Neck Cancer | April 11, 2023
Laryngeal squamous cell carcinoma (LSCC) is the most common squamous cell carcinoma; However, according to Lvsheng Qian ...
Rob DillardHead and Neck Cancer | April 11, 2023
A new study which analyzed price transparency and price variation for the treatment of thyroid cancer show that not ...
Rob DillardHead and Neck Cancer | April 11, 2023
A new study shows that people living in regions with high levels of artificial light at night face a higher risk of ...
Rob DillardHead and Neck Cancer | April 11, 2023
Patients undergoing head and neck cancer surgery do not have an increased risk of SARS-CoV-2 (COVID-19) infection, ...
Kaitlyn D’OnofrioHead and Neck Cancer | April 11, 2023
For patients with head and neck cancer (HNC), the prognosis may not be the greatest. Five-year survival ranges from 30% ...
Rob DillardHead and Neck Cancer | April 11, 2023
Oral cancer is more likely to spread in patients who experience high levels of pain, according to a study published in ...
Advertisement
Advertisement
Advertisement
Latest News

December 9, 2024